宫颈癌预防——宫颈筛查：不断发展的科学
Cervical cancer prevention--cervical screening: science in evolution.
作者信息
Safaeian Mahboobeh, Solomon Diane, Castle Philip E
机构信息
Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health/DHHS, 6120 Executive Blvd., Rockville, MD 20852, USA.
出版信息
Obstet Gynecol Clin North Am. 2007 Dec;34(4):739-60, ix. doi: 10.1016/j.ogc.2007.09.004.
Abstract
The incidence and mortality of cervical cancer in the United States has declined by more than 70% since the 1950s. This decline is attributed mainly to the introduction of Papanicolaou's test in the 1940s. Cervical cancer, however, remains the second most frequent of all female malignancies worldwide, with 80% of the cases occurring in resource-poor countries. This disparity is attributed primarily to the lack of screening and treatment of precancerous lesions. This article describes the traditional methods of screening for cervical cancer and innovative methods that might help overcome financial and cultural barriers to more widespread screening.
摘要
自20世纪50年代以来，美国宫颈癌的发病率和死亡率下降了70%以上。这种下降主要归因于20世纪40年代引入的巴氏试验。然而，宫颈癌仍是全球所有女性恶性肿瘤中第二常见的，80%的病例发生在资源匮乏的国家。这种差异主要归因于癌前病变筛查和治疗的缺乏。本文介绍了宫颈癌的传统筛查方法以及可能有助于克服财务和文化障碍以实现更广泛筛查的创新方法。
相似文献
1
Cervical cancer prevention--cervical screening: science in evolution.
Obstet Gynecol Clin North Am. 2007 Dec;34(4):739-60, ix. doi: 10.1016/j.ogc.2007.09.004.
2
Is cervical screening necessary in older women?
Cytopathology. 2001 Dec;12(6):351-3. doi: 10.1046/j.1365-2303.2001.00356.x.
3
Liquid-based cytology in cervical screening: a rapid and systematic review.
Health Technol Assess. 2000;4(18):1-73.
4
5
Does cervical cancer screening do more harm than good?
Nurs Times. 2001;97(29):20.
6
Is it reality or an illusion that liquid-based cytology is better than conventional cervical smears?
Cytopathology. 2002 Feb;13(1):66. doi: 10.1046/j.1365-2303.2002.0362c.x.
7
Screening for cervical cancer, a priority in Zimbabwe?
Cent Afr J Med. 2000 Mar;46(3):81-6. doi: 10.4314/cajm.v46i3.8528.
8
Implementing recommendations for the early detection of breast and cervical cancer among low-income women.
MMWR Recomm Rep. 2000 Mar 31;49(RR-2):37-55.
9
Screening for cervical cancer in the developing world.
Best Pract Res Clin Obstet Gynaecol. 2005 Aug;19(4):517-29. doi: 10.1016/j.bpobgyn.2005.02.005. Epub 2005 Mar 26.
10
Effective screening programmes for cervical cancer in low- and middle-income developing countries.
Bull World Health Organ. 2001;79(10):954-62. Epub 2001 Nov 1.
引用本文的文献
1
A Novel Serum-Based Bioassay for Quantification of Cancer-Associated Transformation Activity: A Case-Control and Animal Study.
Diagnostics (Basel). 2025 Aug 6;15(15):1975. doi: 10.3390/diagnostics15151975.
2
AI in Cervical Cancer Cytology Diagnostics: A Narrative Review of Cutting-Edge Studies.
Bioengineering (Basel). 2025 Jul 16;12(7):769. doi: 10.3390/bioengineering12070769.
3
Comparative Analysis of Serum N-Glycosylation in Endometriosis and Gynecologic Cancers.
Int J Mol Sci. 2025 Apr 25;26(9):4105. doi: 10.3390/ijms26094105.
4
Few-Layer Graphene-Based Optical Nanobiosensors for the Early-Stage Detection of Ovarian Cancer Using Liquid Biopsy and an Active Learning Strategy.
Cells. 2025 Mar 4;14(5):375. doi: 10.3390/cells14050375.
5
Gynecologic Cancer Screening and Prevention: State of the Science and Practice.
Curr Treat Options Oncol. 2025 Mar;26(3):167-178. doi: 10.1007/s11864-025-01301-z. Epub 2025 Feb 27.
6
HPV-Related Cancers in Bosnia and Herzegovina: A Comprehensive Review.
Acta Med Acad. 2024 Dec;53(3):237-273. doi: 10.5644/ama2006-124.458.
7
The Future of Cervical Cancer Screening.
Int J Womens Health. 2024 Oct 23;16:1715-1731. doi: 10.2147/IJWH.S474571. eCollection 2024.
8
Early adoption of innovation in HPV prevention strategies: closing the gap in cervical cancer.
Ecancermedicalscience. 2024 Sep 11;18:1762. doi: 10.3332/ecancer.2024.1762. eCollection 2024.
9
BD SurePath Direct to Slide (DTS) cervical cytology: Migrating the benefits of liquid-based cytology to low-resource settings.
Am J Clin Pathol. 2024 Jun 24;162(6):559-69. doi: 10.1093/ajcp/aqae068.
10
An improved approach for automated cervical cell segmentation with PointRend.
Sci Rep. 2024 Jun 20;14(1):14210. doi: 10.1038/s41598-024-64583-7.
本文引用的文献
1
Human papillomavirus and cervical cancer.
Lancet. 2007 Sep 8;370(9590):890-907. doi: 10.1016/S0140-6736(07)61416-0.
2
Biomarkers in cervical cancer screening.
Dis Markers. 2007;23(4):315-30. doi: 10.1155/2007/678793.
3
Commentary: Liquid automation refreshes Dr Papanicolaou.
BMJ. 2007 Jul 7;335(7609):35-6. doi: 10.1136/bmj.39260.482616.DE.
4
Accuracy of reading liquid based cytology slides using the ThinPrep Imager compared with conventional cytology: prospective study.
BMJ. 2007 Jul 7;335(7609):31. doi: 10.1136/bmj.39219.645475.55. Epub 2007 Jun 29.
5
Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significance.
Obstet Gynecol. 2007 Jun;109(6):1325-31. doi: 10.1097/01.AOG.0000263461.71732.40.
6
Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial.
BMJ. 2007 Jul 7;335(7609):28. doi: 10.1136/bmj.39196.740995.BE. Epub 2007 May 21.
7
Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update.
Int J Cancer. 2007 Aug 1;121(3):621-32. doi: 10.1002/ijc.22527.
8
DNA extraction: an understudied and important aspect of HPV genotyping using PCR-based methods.
J Virol Methods. 2007 Jul;143(1):45-54. doi: 10.1016/j.jviromet.2007.02.006. Epub 2007 Mar 30.
9
Randomized evaluation trial on automation-assisted screening for cervical cancer: results after 777,000 invitations.
J Med Screen. 2007;14(1):23-8. doi: 10.1258/096914107780154468.
10
Prevalence of HPV infection among females in the United States.
JAMA. 2007 Feb 28;297(8):813-9. doi: 10.1001/jama.297.8.813.
Zotero 插件